Yervoy Global Market Report 2025

Yervoy Global Market Report 2025 ) – By Type (40 ml, 10 ml), By Clinical Indication (Melanoma, Non-Small Cell Lung Cancer (NSCLC), Renal Cell Carcinoma (RCC), Colorectal Cancer (CRC)), By Distribution Channel (Hospitals, Oncology Clinics, Retail Pharmacies, Online Pharmacies), By End User (Adult, Geriatric) – Market Size, Trends, And Global Forecast 2025-2034

Name: Yervoy Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Yervoy Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

Yervoy Market Definition

Yervoy is a prescription medication containing ipilimumab, a monoclonal antibody used in the treatment of certain cancers by enhancing the body's immune system to fight cancer cells. It is a monoclonal antibody that works by blocking the CTLA-4 (cytotoxic T-lymphocyte antigen 4) receptor on T-cells, a protein that normally downregulates the immune response.

The main types of yervoy are 40 ml, and 10 ml. The Yervoy 40 mg dose refers to a specific concentration of ipilimumab, a monoclonal antibody used in immunotherapy, administered to patients to activate the immune system by inhibiting CTLA-4, a protein receptor that downregulates immune responses, thereby enhancing the body's ability to target and destroy cancer cells in conditions such as metastatic melanoma and other cancers as per the prescribed treatment regimen. The various indication includes melanoma, non-small cell lung cancer (nsclc), renal cell carcinoma (rcc), and colorectal cancer (crc). These are distributed through various distribution channels such as hospitals, oncology clinics, retail pharmacies, online pharmacies and used by various end users such as adults, geriatric

Yervoy Market Segmentation

The yervoymarket covered in this report is segmented –

1) By Type: 40 ml, 10 ml

2) By Clinical Indication: Melanoma, Non-Small Cell Lung Cancer (NSCLC), Renal Cell Carcinoma (RCC), Colorectal Cancer (CRC)

3) By Distribution Channel: Hospitals, Oncology Clinics, Retail Pharmacies, Online Pharmacies

4) By End User: Adult, Geriatric

Yervoy Market Size and growth rate 2025 to 2029: Graph

Yervoy Market Size 2025 And Growth Rate

The yervoy market size has grown rapidly in recent years. It will grow from $5,420 million in 2024 to $6,010 million in 2025 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to increasing cancer incidence, growing focus on combination therapies, regulatory approvals for new indications, advancements in biologic manufacturing, increased investments in oncology research.

Yervoy Market Growth Forecast

The yervoy market size is expected to see rapid growth in the next few years. It will grow to $9,000 million in 2029 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to rising consumer demand in emerging markets, expanding applications across industries, advancements in clinical research, increasing investment in biologics, and global market expansion. Major trends in the forecast period include expansion of combination immunotherapies, broadening of indications for new cancers, advancements in biologic drug delivery systems, increasing role of artificial intelligence (AI) in oncology, and patient-centric drug development.

Book your 30 minutes free consultation with our research experts

Yervoy Market Driver: Increasing Incidence of Melanoma Drives Demand for Advanced Treatment Solutions

The increasing incidence of melanoma is expected to propel the growth of the yervoy market going forward. Melanoma refers to a type of skin cancer that develops in the melanocytes, which produce the pigment melanin responsible for skin color. The rising incidence of melanoma is driven by increased sun exposure, lifestyle changes, and UV radiation due to ozone depletion. Improved awareness and diagnostic methods also contribute to more cases being detected. Yervoy, by targeting the CTLA-4 protein to boost the immune system's ability to detect and attack cancer cells, has proven particularly beneficial for melanoma patients, offering improved survival rates and durable responses even in advanced stages of the disease. For instance, in January 2024, according to the American Cancer Society, a US- based non-profit organization dedicated to eliminating cancer, reported that approximately 100,640 new melanoma cases are expected to be diagnosed in the United States in 2024, with 59,170 cases in men and 41,470 cases in women. Additionally, the organization estimates that 8,290 people will die from melanoma in 2024, with 5,430 men and 2,860 women affected. Therefore, increasing incidence of melanoma drives the yervoy market.

Global Yervoy Market Major Players

Major companies operating in the yervoy market include Bristol-Myers Squibb, Merck & Co., Ono Pharmaceutical

Global Yervoy Market Trend: Innovative Combination Therapies Yervoy And Opdivo Lead The Way In Cancer Treatment Advancements

The key trend in the yervoy market is focusing on developing innovative combination therapies, such as a combination of Opdivo (nivolumab) and yervoy (ipilimumab), to enhance treatment efficacy and broaden the range of cancer indications. The combination of Opdivo (nivolumab) and Yervoy (ipilimumab) synergistically boosts the immune response by targeting complementary immune checkpoint pathways, enhancing efficacy in treating various cancers such as melanoma and renal cell carcinoma. For instance, in June 2024, Bristol Myers Squibb, a US-based company that manufactures pharmaceuticals, announced significant results from the CheckMate-9DW trial, which evaluated the combination of Opdivo (nivolumab) and Yervoy (ipilimumab) as a first-line treatment for patients with advanced hepatocellular carcinoma (HCC). The trial demonstrated that this dual immunotherapy regimen significantly improved overall survival (OS) compared to the standard treatments, lenvatinib or sorafenib. The combination of Opdivo and Yervoy showed a statistically significant improvement in overall survival for patients with advanced HCC compared to those treated with either lenvatinib or sorafenib.

Yervoy Market Merger And Acquisition: Ono And Bristol-Myers Squibb KK Collaborate To Expand Opdivo And Yervoy Use In Advanced Colorectal Cancer

In September 2024, Ono Pharmaceutical, a Japan-based company that manufactures pharmaceuticals, partnered with Bristol-Myers Squibb KK (BMS KK). This partnership aims to expand the use of Opdivo and Yervoy in treating unresectable advanced or recurrent microsatellite instability-high (MSI-H) colorectal cancer. Through this collaboration, Ono aims to enhance its portfolio of immuno-oncology therapies and address unmet medical needs in cancer treatment. Bristol-Myers Squibb is a Japan-based company that offers yervoy.

Regional Outlook For The Global Yervoy Market

North America was the largest region in the yervoy market in 2024. The regions covered in the yervoy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the yervoy market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Yervoy Market?

The yervoy market consists of sales of ipilimumab and combination therapies. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Yervoy Industry?

The yervoy market research report is one of a series of new reports from The Business Research Company that provides yervoy market statistics, including yervoy industry global market size, regional shares, competitors with a yervoy market share, detailed yervoy market segments, market trends, and opportunities, and any further data you may need to thrive in the yervoy industry. This yervoy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Yervoy Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	CAGR of 10.6% from 2025 to 2034
Revenue Forecast In 2034	2024
Growth Rate	2019-2024
Base Year For Estimation	2025 - 2029 - 2034
Actual Estimates/Historical Data	Revenue in USD Billion and CAGR from 2025 to 2034
Forecast Period	1) By Type: 40 ml, 10 ml 2) By Clinical Indication: Melanoma, Non-Small Cell Lung Cancer (NSCLC), Renal Cell Carcinoma (RCC), Colorectal Cancer (CRC) 3) By Distribution Channel: Hospitals, Oncology Clinics, Retail Pharmacies, Online Pharmacies 4) By End User: Adult, Geriatric
Market Representation	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Segments Covered	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Regional Scope	Bristol-Myers Squibb, Merck & Co., Ono Pharmaceutical
Country Scope	Request for Sample
Key Companies Profiled	Explore Purchase Options
Customization Scope
Pricing And Purchase Options

1. Executive Summary

2. Yervoy Market Characteristics

3. Yervoy Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Yervoy Market Trends And Strategies

5. Yervoy Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Yervoy Growth Analysis And Strategic Analysis Framework

6.1. Global Yervoy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Yervoy Market Growth Rate Analysis

6.4. Global Yervoy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

6.5. Global Yervoy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

6.6. Global Yervoy Total Addressable Market (TAM)

7. Global Yervoy Market Pricing Analysis & Forecasts

8. Yervoy Market Segmentation

8.1. Global Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

40 ml

10 ml

8.2. Global Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Melanoma

Non-Small Cell Lung Cancer (NSCLC)

Renal Cell Carcinoma (RCC)

Colorectal Cancer (CRC)

8.3. Global Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Oncology Clinics

Retail Pharmacies

Online Pharmacies

8.4. Global Yervoy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Adult

Geriatric

9. Global Yervoy Market Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Yervoy Market Regional And Country Analysis

10.1. Global Yervoy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. Global Yervoy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Yervoy Market

11.1. Asia-Pacific Yervoy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Asia-Pacific Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Asia-Pacific Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Yervoy Market

12.1. China Yervoy Market Overview

12.2. China Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

12.3. China Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

12.4. China Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Yervoy Market

13.1. India Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. India Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. India Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Yervoy Market

14.1. Japan Yervoy Market Overview

14.2. Japan Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. Japan Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. Japan Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Yervoy Market

15.1. Australia Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.2. Australia Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Australia Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Yervoy Market

16.1. South Korea Yervoy Market Overview

16.2. South Korea Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. South Korea Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.4. South Korea Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Yervoy Market

17.1. Western Europe Yervoy Market Overview

17.2. Western Europe Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Western Europe Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.4. Western Europe Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Yervoy Market

18.1. UK Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. UK Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. UK Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Yervoy Market

19.1. Germany Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Germany Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Germany Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Yervoy Market

20.1. France Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. France Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. France Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Yervoy Market

21.1. Eastern Europe Yervoy Market Overview

21.2. Eastern Europe Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Yervoy Market

22.1. North America Yervoy Market Overview

22.2. North America Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. North America Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.4. North America Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Yervoy Market

23.1. USA Yervoy Market Overview

23.2. USA Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. USA Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. USA Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Yervoy Market

24.1. Canada Yervoy Market Overview

24.2. Canada Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. Canada Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. Canada Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Yervoy Market

25.1. South America Yervoy Market Overview

25.2. South America Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. South America Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. South America Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Yervoy Market

26.1. Middle East Yervoy Market Overview

26.2. Middle East Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. Middle East Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. Middle East Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Yervoy Market

27.1. Africa Yervoy Market Overview

27.2. Africa Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Africa Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.4. Africa Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Yervoy Market Competitive Landscape And Company Profiles

28.1. Yervoy Market Competitive Landscape

28.2. Yervoy Market Company Profiles

28.2.1. Bristol-Myers Squibb Overview, Products and Services, Strategy and Financial Analysis

28.2.2. Merck & Co. Overview, Products and Services, Strategy and Financial Analysis

28.2.3. Ono Pharmaceutical Overview, Products and Services, Strategy and Financial Analysis

29. Global Yervoy Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Yervoy Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Yervoy Market

32. Recent Developments In The Yervoy Market

33. Yervoy Market High Potential Countries, Segments and Strategies

33.1 Yervoy Market In 2029 - Countries Offering Most New Opportunities

33.2 Yervoy Market In 2029 - Segments Offering Most New Opportunities

33.3 Yervoy Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Yervoy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Yervoy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Yervoy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Asia-Pacific, Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Asia-Pacific, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: China, Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: China, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: India, Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: India, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: Japan, Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: Japan, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Australia, Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Australia, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: South Korea, Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: South Korea, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: South Korea, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Western Europe, Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Western Europe, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Western Europe, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: UK, Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: UK, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: UK, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Germany, Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Germany, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Germany, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: France, Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: France, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: France, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Eastern Europe, Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Eastern Europe, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Eastern Europe, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: North America, Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: North America, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: North America, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: USA, Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: USA, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: USA, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Canada, Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Canada, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Canada, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: South America, Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: South America, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: South America, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Middle East, Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Middle East, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Middle East, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Africa, Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Africa, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: Africa, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: Bristol-Myers Squibb Financial Performance

Table 61: Merck & Co. Financial Performance

Table 62: Ono Pharmaceutical Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Yervoy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Yervoy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Yervoy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Asia-Pacific, Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Asia-Pacific, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: China, Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: China, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: India, Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: India, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: Japan, Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: Japan, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Australia, Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Australia, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: South Korea, Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: South Korea, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: South Korea, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Western Europe, Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Western Europe, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Western Europe, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: UK, Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: UK, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: UK, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Germany, Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Germany, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Germany, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: France, Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: France, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: France, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Eastern Europe, Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Eastern Europe, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Eastern Europe, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: North America, Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: North America, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: North America, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: USA, Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: USA, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: USA, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Canada, Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Canada, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Canada, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: South America, Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: South America, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: South America, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Middle East, Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Middle East, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Middle East, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Africa, Yervoy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Africa, Yervoy Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: Africa, Yervoy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: Bristol-Myers Squibb Financial Performance

Figure 61: Merck & Co. Financial Performance

Figure 62: Ono Pharmaceutical Financial Performance

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Global Anticoagulants Market 2022 – Market Opportunities And Strategies

What Is The Compression Therapy Market Overview In 2022?

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the GI drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the covid-19 current therapy market research report 2022 with industry size, share, segments and market growth

Autoimmune Treatment Global Market Report 2025 – By Product (Consumables and Assay Kits, Instruments, Services), By Service Type (Consultation and Diagnosis, Therapy and monitoring, Drug development), By Disease (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren’s Syndrome, Thyroiditis, Scleroderma, Other Diseases), By Drug Class (Anti-Inflammatory, Anti-Hyperglycemic, NSAIDs, Interferons, Other Drug Class), By End User (Clinical Laboratories, Hospitals, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

PD-1 and PDL1 Inhibitors/ Immune Checkpoint Inhibitors Global Market Report 2025 – By Product (Nivolumab, Pembrolizumab, Atezolizumab, Avelumab, Durvalumab), By Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies), By Application (Lung Cancer, Bladder Cancer, Melanoma, Hodgkin Lymphoma, Colorectal Cancer, Other Applications), By End-Users (Hospitals, Specialty Clinics, Academic and Research Institutions) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Autoimmune Disease Diagnosis Global Market Report 2025 – By Product (Consumables And Assay Kits, Instruments), By End User (Clinical Laboratories, Hospitals, Others), By Test Type (Routine Laboratory Tests, Autoantibodies Tests, Immunologic Tests, Other Tests) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Natural Immune Booster Global Market Report 2025 – By Product Type (Herbal Supplements, Vitamins And Minerals, Probiotics, Functional Foods And Beverages, Essential Oils, Other Product Types), By Distribution Channel (Health Food Stores, Online Retailers, Pharmacies And Drug Stores, Supermarkets And Hypermarkets, Other Distribution Channels), By Application (Immune System Support, Cold And Flu Relief, Allergy Management, Respiratory Health, Digestive Health, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Hyperimmune Globulins Global Market Report 2025 – By Type (Hepatitis B Hyperimmune Globulin, Rabies Hyperimmune Globulin, Tetanus Hyperimmune Globulin, Cytomegalovirus (CMV) Hyperimmune Globulin, Varicella-Zoster Virus (VZV) Hyperimmune Globulin, Respiratory Syncytial Virus (RSV) Hyperimmune Globulin, Other Types), By Route Of Administration (Intramuscular, Intravenous), By Application (Government Institution, Private Sector, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Hereditary Cancer Testing Global Market Report 2025 – By Test Type( Multi Panel Test, Single-site Genetic Test), By Indication( Breast Cancer, Ovarian Cancer, Colorectal Cancer, Other Indications), By End user( Hospital, Clinics, Diagnostic Centers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Urothelial Cancer Drugs Global Market Report 2025 – By Type( Urothelial Carcinoma, Squamous Cell Carcinoma, Adenocarcinoma), By Treatment( Immunotherapy, Chemotherapy, Preservation Therapy), By Distribution Channel( Hospital Pharmacies, Specialty Clinics, Cancer Institutes, Ambulatory Surgical Centers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Anti-Cancer MAbS Global Market Report 2025 – By Type (Murine Antibodies, Chimeric Antibodies, Humanized Antibodies, Other Types), By Application (Blood Cancer, Breast Cancer, Lung Cancer, Melanoma, Colorectal Cancer, Liver Cancer, Other Applications), By End User (Hospitals, Research Institutes, Other End Users ) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Yervoy market?

How will the Yervoy market drivers and restraints affect the market dynamics? What forces will shape the Yervoy industry going forward?

The Yervoy market major growth driver - Increasing Incidence of Melanoma Drives Demand for Advanced Treatment Solutions. For further insights on the Yervoy market, request a sample here

What is the forecast market size or the forecast market value of the Yervoy market?

The Yervoy market size has grown strongly in recent years. The yervoy market size has grown rapidly in recent years. It will grow from $5,420 million in 2024 to $6,010 million in 2025 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to increasing cancer incidence, growing focus on combination therapies, regulatory approvals for new indications, advancements in biologic manufacturing, increased investments in oncology research. The yervoy market size is expected to see rapid growth in the next few years. It will grow to $9,000 million in 2029 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to rising consumer demand in emerging markets, expanding applications across industries, advancements in clinical research, increasing investment in biologics, and global market expansion. Major trends in the forecast period include expansion of combination immunotherapies, broadening of indications for new cancers, advancements in biologic drug delivery systems, increasing role of artificial intelligence (AI) in oncology, and patient-centric drug development. For further insights on the Yervoy market, request a sample here

How is the Yervoy market segmented?

The yervoymarket covered in this report is segmented –
1) By Type: 40 ml; 10 ml
2) By Clinical Indication: Melanoma; Non-Small Cell Lung Cancer (NSCLC); Renal Cell Carcinoma (RCC); Colorectal Cancer (CRC)
3) By Distribution Channel: Hospitals; Oncology Clinics; Retail Pharmacies; Online Pharmacies
4) By End User: Adult; Geriatric For further insights on the Yervoy market, request a sample here

Which region has the largest share of the Yervoy market? What are the other regions covered in the report?

Who are the major players in the Yervoy market?

Major companies operating in the yervoy market include Bristol-Myers Squibb, Merck & Co., Ono Pharmaceutical . For further insights on the Yervoy market, request a sample here.

What are the key trends in the Yervoy market?

Major trends in the Yervoy market include Innovative Combination Therapies Yervoy And Opdivo Lead The Way In Cancer Treatment Advancements. For further insights on the Yervoy market, request a sample here.

What are the major opportunities in the Yervoy market? What are the strategies for the Yervoy market?

For detailed insights on the major opportunities and strategies in the Yervoy market, request a sample here.

How does the Yervoy market relate to the overall economy and other similar markets?

For detailed insights on Yervoy's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Yervoy industry?

For detailed insights on the mergers and acquisitions in the Yervoy industry, request a sample here.

What are the key dynamics influencing the Yervoy market growth? SWOT analysis of the Yervoy market.

For detailed insights on the key dynamics influencing the Yervoy market growth and SWOT analysis of the Yervoy industry, request a sample here.